Cellular Therapy in NSCLC: Between Myth and Reality
Authors:
Open Access
- 30 August 2023
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 25 (10) , 1161-1174
Abstract
Purpose of Review: In this paper, we review the current state and modalities of adoptive cell therapies (ACT) in non-small cell lung carcinoma (NSCLC). We also discuss the challenges hampering the use of ACT and the approaches to overcome these barriers. Recent Findings: Several trials are ongoing investigating the three main modalities of T cell-based ACT: tumor-infiltrating lymphocytes (TILs), genetically engineered T-cell receptors (TCRs), and chimeric antigen receptor (CAR) T cells. The latter, in particular, has revolutionized the treatment of hematologic malignancies. However, the efficacy against solid tumor is still sparse. Major limitations include the following: severe toxicities, restricted infiltration and activation within the tumors, antigen escape and heterogeneity, and manufacturing issues. Summary: ACT is a promising tool to improve the outcome of metastatic NSCLC, but significant translational and clinical research is needed to improve its application and expand the use in NSCLC.Keywords
Funding Information
- University of Lausanne
This publication has 73 references indexed in Scilit:
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human CancersThe American Journal of Pathology, 2012
- T Cell Receptor Gene Therapy for CancerHuman Gene Therapy, 2009
- Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinomaLaboratory Investigation, 2008
- Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancerCancer Science, 2007
- B7-H3 and B7-H4 expression in non-small-cell lung cancerLung Cancer, 2006
- Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cellsClinical Immunology, 2006
- Identification of a New Cancer/Germline Gene,KK-LC-1, Encoding an Antigen Recognized by Autologous CTL Induced on Human Lung AdenocarcinomaCancer Research, 2006
- Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Redirecting Migration of T Cells to Chemokine Secreted from Tumors by Genetic Modification with CXCR2Human Gene Therapy, 2002
- Frequencies of HLA-A2 alleles in five U.S. population groupsHuman Immunology, 2000